Hematology Congresses | Takeda U.S. Medical

Scientific Congresses in Hematology

Selected Data Presentations

Select "Upcoming" to see a list of future scientific congresses in hematology. Select "Past" to review data and presentations from recent congresses. This is not intended to be a comprehensive resource of all congresses and congress materials across therapeutic and disease areas.

Congress materials may include information about investigational use(s) of compounds/products that are not approved for use by the U.S. Food and Drug Administration (FDA) and/or are inconsistent with the Prescribing Information. Takeda does not recommend the use of any Takeda product beyond the approved labeling. Any decisions regarding the usage of a Takeda product beyond the approved labeling is left to the discretion of the healthcare professional. Takeda makes no representations about whether investigational compounds or unapproved uses will be approved by the FDA.


Upcoming & Past Conferences

  • Upcoming

  • Past

Academy of Managed Care Pharmacy Nexus (AMCP Nexus), 2023

October 16 - 19, 2023 | Link to Event
Annual event with more than 2,500 members and non-members of the AMCP to engage on the latest innovations and most intentional networking in managed care pharmacy.

American Society of Hematology (ASH), 2023

December 9 - 12, 2023 | Link to Event
The premier global congress from the world's largest professional society serving both clinicians and scientists working in malignant and classical hematology.

International Society on Thrombosis and Haemostasis (ISTH), 2023

June 24 - 28, 2023
Global congress featuring the world’s leading experts on thrombosis, hemostasis and vascular biology presenting the most recent advances, the latest science, and the newest clinical applications designed to improve patient care.

European Hematology Association (EHA), 2023

June 8 - 15, 2023
An immersive hematology event discussing cutting-edge approaches to diagnosis and treatment, including clinical and translational research, for medical professionals, national hematology societies, patient groups, medical industry and media worldwide.

Academy of Managed Care Pharmacy (AMCP), 2023

March 21 - 24, 2023
Large assembly of pharmacy and healthcare professionals dedicated to the issues of managed care pharmacy offering immersive education sessions and keynote presentations.

HTRS Scientific Symposium (HTRS), 2023

March 10 - 12, 2023
A comprehensive scientific meeting designed to advance research and clinical practice related to disorders of hemostasis and thrombosis.

European Association for Haemophilia and Allied Disorders (EAHAD), 2023

February 7 - 10, 2023
Annual congress including physicians, nurses, physiotherapists and psychosocial professionals to promote education, supporting research and improving the clinical care of inherited or acquired bleeding disorders.

American Society of Hematology (ASH), 2022

December 10 - 13, 2022
The premier global congress from the world's largest professional society serving both clinicians and scientists working in malignant and classical hematology.

  • Real-World Analysis of Healthcare Resource Utilization and Costs among Patients Diagnosed with Von Willebrand Disease and Angiodysplasia
  • Development of a Machine Learning Algorithm for Early Diagnosis of Persons with Von Willebrand Disease Using Real-World Data

Adynovate® [Antihemophilic Factor (Recombinant), PEGylated] & Advate® [Antihemophilic Factor (Recombinant)]

  • Risk of Intracranial Hemorrhage in US Patients with Hemophilia A: Real-World Retrospective Cohort Study Using the ATHNdataset

NHF Bleeding Disorders Conference (NHF), 2022

August 25 - 27, 2022
Annual conference featuring the latest updates from NHF on research, novel treatments, educational events, advocacy priorities, and community testimonials.

  • Healthcare Resource Utilization and Costs in Males and Females With Hemophilia A and Hemophilia A Carriers: A Retrospective Observational Analysis of US Commercial and Medicaid Claims Databases

Thrombosis and Hemostasis Societies of North America (THSNA), 2022

August 16 - 18, 2022
A summit of 10 of the leading non-profit organizations in hemostasis and thrombosis, providing expertise and insight on improving patient care.

  • Hemophilia A Carriers Compared with the General Female Population: US Analysis of Healthcare Burden
  • Impact of Switching Prophylaxis Treatment from Factor VIII to Emicizumab in Hemophilia A Patients without Inhibitors
  • Clinical Outcomes in Patients with Severe ADAMTS13 Deficiency Across US Hospitals